Overview

Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

This 24 month randomized research study will evaluate whether doxycycline can 1) slow the deterioration or improve retinal function and/or 2) induce regression, or slow progression, of diabetic retinopathy in participants over 18 years of age with type 1 or type 2 diabetes with severe non-proliferative or early proliferative diabetic retinopathy.

Phase:

Phase 2

Details

Lead Sponsor:

Thomas Gardner
Thomas W. Gardner

Collaborator:

Juvenile Diabetes Research Foundation

Treatments:

Doxycycline